World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3389)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

HTML

2749

Figures (1-2)

141

Tables (1-2)

127

Sum=3079

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

114

Sum=149

Jun 21, 2024 (publication date) through Dec 1, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Rochoń J, Kalinowski P, Szymanek-Majchrzak K, Grąt M. Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2024; 30(23): 2964-2980 [PMID: 38946874 DOI: 10.3748/wjg.v30.i23.2964]
URL:	https://www.wjgnet.com/1948-5182/full/v30/i23/2964.htm

Number	Citing Articles
1	Li Lin, Shaowei Xiang, Yuan Chen, Yan Liu, Dingwen Shen, Xiaoping Yu, Zhe Wu, Yanling Sun, Kequan Chen, Jia Luo, Guilai Wei, Zhiguo Wang, Zhifeng Ning. Gut microbiota: Implications in pathogenesis and therapy to cardiovascular disease (Review). Experimental and Therapeutic Medicine 2024; 28(5) doi: 10.3892/etm.2024.12716
2	Merve Guney-Coskun, Metin Basaranoglu. Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy. World Journal of Gastroenterology 2024; 30(43): 4682-4688 doi: 10.3748/wjg.v30.i43.4682 Abstract(102) \| Core Tip(72) \| Full Article(HTML)(718) \| Full Article with Cover (PDF)-1577K(16) \| Audio-1593K(1) \| Peer-Review Report-245K(16) \| Answering Reviewers-147K(9) \| Full Article (PDF)-1223K(44) \| Full Article (XML)-96K(10) \| Times Cited (0) \| Total Visits (1136) \| Open
3	Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875 Abstract(152) \| Core Tip(157) \| Full Article(HTML)(359) \| Full Article with Cover (PDF)-639K(27) \| Audio-785K(5) \| Peer-Review Report-230K(17) \| Answering Reviewers-209K(18) \| Full Article (PDF)-410K(30) \| Full Article (XML)-117K(20) \| Times Cited (0) \| Total Visits (1102) \| Open
4	Chun-Han Cheng, Wen-Rui Hao, Tzu-Hurng Cheng. Role of intestinal glucagon-like peptide-1 in hypoglycemia response impairment in type 1 diabetes. World Journal of Diabetes 2024; 15(11): 2237-2241 doi: 10.4239/wjd.v15.i11.2237 Abstract(95) \| Core Tip(95) \| Full Article(HTML)(1178) \| Full Article with Cover (PDF)-801K(24) \| Audio-213K(0) \| Peer-Review Report-237K(8) \| Answering Reviewers-97K(11) \| Full Article (PDF)-365K(25) \| Full Article (XML)-41K(13) \| Times Cited (0) \| Total Visits (1572) \| Open